US Patent Application 20100063156 - ANANDAMIDE
InventorUS Classes514/627, Carbon to carbon unsaturation in R564/208Hydroxy, bonded directly to carbon, or ether in an acyclic substituent E (H of -OH may be replaced by a substituted or unsubstituted ammonium ion or a Group IA or IIA light metal)Attorney, Agent or FirmForeign Documents
International ClassesA61K 31/16C07C 233/20 A61P 3/00 Abstract textThe present invention describes provides the use of anandamide for the manufacture of a nutraceutical for oral intake preferably a medicament for reducing appetite, giving a satiety effect, preventing or reducing inflammatory bowel disease or preventing or reducing irritable bowel syndrome |
| ||||||||||||||
